Ordinary Adjustment | Solactive Transatlantic Healthcare Equity Index | Effective Date 8th October 2025
Solactive Transatlantic Healthcare Equity Index:
In the ordinary adjustment, the following composition will be implemented effective open 8th October 2025:
ABBOTT LABORATORIES |
ABBVIE INC |
ADDUS HOMECARE CORP |
ALCON INC |
AMGEN INC |
BIOMERIEUX |
BOSTON SCIENTIFIC CORP |
BRISTOL-MYERS SQUIBB CO |
CIGNA GROUP |
COLOPLAST AS CLASS B |
CONCENTRA GROUP HOLDINGS PARENT ORD |
CONVATEC GROUP PLC |
DAVITA INC |
DIASORIN SPA |
EDWARDS LIFESCIENCES CORP |
ENCOMPASS HEALTH CORP |
ENSIGN GROUP INC |
ESSILORLUXOTTICA |
FRESENIUS MEDICAL CARE AG & CO KGAA |
GILEAD SCIENCES INC |
GSK PLC |
HALEON PLC |
HIKMA PHARMACEUTICALS PLC |
INTEGER HOLDINGS CORP |
JOHNSON & JOHNSON |
KONINKLIJKE PHILIPS NV |
LABCORP HOLDINGS INC |
LONZA GROUP AG |
MEDTRONIC PLC |
MERCK & CO. INC. |
MERCK KGAA |
NOVARTIS AG |
OPTION CARE HEALTH INC |
ORION OYJ CLASS B |
PFIZER INC |
PRESTIGE CONSUMER HEALTHCARE INC |
QIAGEN NV |
QUEST DIAGNOSTICS INC |
RECORDATI SPA |
RESMED INC |
ROCHE HOLDING AG |
ROYALTY PHARMA PLC- CL A |
SANOFI SA |
SIEMENS HEALTHINEERS AG |
SONOVA HOLDING AG |
STERIS PLC |
STRAUMANN HOLDING AG |
STRYKER CORP |
ZIMMER BIOMET HOLDINGS INC |
ZOETIS INC |